Gencurix Inc. (KOSDAQ:229000)

Revenue by Product

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Cancer Diagnosis (Prognostic Diagnosis + Companion Diagnosis)	4.62B
Cancer Diagnosis (Prognostic Diagnosis + Companion Diagnosis) Growth	92.37%
Other	510.35M
Other Growth	159.24%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
South Korea	4.70B
South Korea Growth	88.67%
Overseas	433.62M
Overseas Growth	297.57%